Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program
PaperCitations, authors & open-access status
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 141 citations, 2021 year and hybrid oa status.
141
Citations
2021
Year
hybrid
OA Status